Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Family Med Prim Care ; 13(2): 627-634, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38605793

ABSTRACT

Background: Tribes are the most socially excluded group in the nation due to their restricted access to healthcare. There are little data on the real burden and distribution of illnesses among tribes. The present study determines the types and patterns of sickness among tribal populations in West Bengal. Methods: Five blocks from five districts in West Bengal were used for this cross-sectional study. Between the years 2018 and 2019, 52,189 patients visited these mobile medical clinics (MMCs), but only 36,128 were included in our study. Data were analyzed using the SPSS software (ver. 27.0). Results: Younger age groups (1-25 years) show higher primary registration compared to other age categories; older age groups (>60 years) show higher repeat registration. High prevalence in infectious diseases (44.5% of the total primary registration) and high repeated cases in NCDs (11.5% to 33.2%), which are nearly three times higher than primary cases (Cramer's V test = 0.29; P = .001) are observed. Among the studied MMCs, Binpur II and Matiali MMC have more than two times the risk of gastrointestinal problems, while Madarihat MMC has more than one time the risk. Garbeta II MMC shows more than three times the risk of NCDs (adjusted odds ratio = 3.97; 95% confidence interval: 3.05-5.17) than the other diseases. Conclusion: The present study shows high prevalence of infectious diseases, injury and pain, NCDs, gastrointestinal problems, and vertigo in tribal populations of West Bengal.

2.
JBI Evid Synth ; 2024 Mar 11.
Article in English | MEDLINE | ID: mdl-38465423

ABSTRACT

OBJECTIVE: The objective of this systematic review is to provide an overview of economic evaluation studies of interventions for neglected tropical diseases in low- and/or middle-income countries. INTRODUCTION: The majority of people most susceptible to neglected tropical diseases reside in low- and middle-income countries and suffer significant economic impact due to these diseases. The World Health Organization suggests utilizing a systematic and cross-cutting approach with multiple interventions to lessen the neglected tropical disease burden. INCLUSION CRITERIA: Studies will be eligible for inclusion if they include economic evaluations of interventions for neglected tropical diseases and are conducted in low- and/or middle-income country settings. METHODS: A preliminary search of MEDLINE (PubMed) was undertaken using MeSH terms, such as neglected tropical disease, economic evaluation, therapeutics, low- and/or middle-income countries. Two reviewers will screen titles and abstracts independently, followed by a full-text review against the inclusion criteria. Disagreements will be resolved by discussion or with a third reviewer. To assess methodological quality, the JBI checklist for economic evaluations will be used. For economic evaluations, data will be extracted using the standardized JBI data extraction form. The Dominance Ranking Matrix will be used to summarize and compare the results of different types of economic evaluations. Cost per quality adjusted life year gained and cost per disability adjusted life year averted will be measures for economic evaluation. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach will be used to assess the certainty of economic evidence, such as resource use and costs. REVIEW REGISTRATION: PROSPERO CRD42017070386.

3.
JBI Evid Synth ; 22(6): 1143-1150, 2024 Jun 01.
Article in English | MEDLINE | ID: mdl-38287736

ABSTRACT

OBJECTIVE: The purpose of this systematic review is to assess the cost-effectiveness of targeted/selective newborn screening compared with universal screening for sickle cell disease across various countries and settings. INTRODUCTION: The incidence of sickle cell disease is a widespread and potentially fatal hematologic disorder that affects thousands of newborns worldwide. The cost of newborn screening creates a burden on households and the economy. INCLUSION CRITERIA: Studies will be eligible for inclusion in the review if they focus on the cost-effectiveness of newborn screening for sickle cell disease, comparing targeted/selective screening with universal screening. METHODS: A preliminary search of MEDLINE (PubMed) was undertaken using MeSH terms, such as sickle cell disease, newborn , and economic evaluations . Two reviewers will screen the titles, abstracts, and full text independently against the inclusion criteria. Disagreements will be resolved by discussion or with a third reviewer. To assess methodological quality, the JBI checklist for economic evaluation will be used. Data will be extracted by 2 reviewers using a modified JBI data extraction form. The JBI dominance ranking matrix for economic evaluations will be used to summarize and compare the results. Cost-effectiveness will be measured on the basis of cost per test/case detected, quality-adjusted life years gained, or disability-adjusted life years averted. The Grading of Recommendations, Assessment, Development and Evaluation (GRADE) assessment will be conducted to evaluate the certainty of economic evidence, such as use of resources and expenditures, and to incorporate the results into the decision-making process. REVIEW REGISTRATION: PROSPERO CRD42017057963.


Subject(s)
Anemia, Sickle Cell , Cost-Benefit Analysis , Neonatal Screening , Systematic Reviews as Topic , Humans , Anemia, Sickle Cell/diagnosis , Anemia, Sickle Cell/epidemiology , Anemia, Sickle Cell/economics , Neonatal Screening/economics , Neonatal Screening/methods , Infant, Newborn , Quality-Adjusted Life Years
4.
JBI Evid Synth ; 22(1): 97-105, 2024 Jan 01.
Article in English | MEDLINE | ID: mdl-37779435

ABSTRACT

OBJECTIVE: The purpose of this systematic review is to assess the available economic evidence of a decentralized care model compared to a centralized model for treating multi-drug-resistant tuberculosis (MDR-TB) in low- and middle-income countries (LMICs). INTRODUCTION: Diseases that affect physiological health create a burden on human livelihoods and the economy. There is a lack of studies examining the economic evaluation of MDR-TB across different countries. A preliminary search identified no published or ongoing reviews on MDR-TB in LMICs. INCLUSION CRITERIA: Studies will be eligible if they include both patients receiving centralized care (ie, care provided by specialist centers through inpatient or outpatient services) and patients receiving decentralized care (ie, care provided by grassroots community workers in peripheral facilities or in the patients' residence) for MDR-TB in LMICs. Eligible studies will report economic evaluations of treatment for MDR-TB. METHODS: A preliminary search of MEDLINE (PubMed) was undertaken using MeSH terms, such as MDR-TB, economic evaluation, therapeutics, LMICs . Two reviewers will independently screen the titles, abstracts, and full text against the inclusion criteria. Disagreements will be resolved through discussion or with a third reviewer. The JBI checklist for economic evaluations will be utilized to evaluate the methodological quality. Data will be extracted using a modified JBI data extraction form for economic evaluations. The Dominance Ranking Matrix, developed by JBI for economic evaluations, will be used to summarize and compare the results of different types of economic evaluations (cost-effectiveness, cost-benefit analysis, cost-utility analysis, or cost-minimization analysis). Cost per quality-adjusted life year gained and cost per disability-adjusted life year averted will be measures for economic evaluation. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach will be used to assess the certainty of economic evidence. REVIEW REGISTRATION: PROSPERO CRD42022368696.


Subject(s)
Cost-Effectiveness Analysis , Tuberculosis, Multidrug-Resistant , Humans , Cost-Benefit Analysis , Developing Countries , Systematic Reviews as Topic , Tuberculosis, Multidrug-Resistant/drug therapy , Tuberculosis, Multidrug-Resistant/epidemiology
5.
Indian J Public Health ; 67(4): 523-526, 2023 Oct 01.
Article in English | MEDLINE | ID: mdl-38934810

ABSTRACT

SUMMARY: In children, body frame size estimation is used to interpret body mass and evaluate growth patterns. The present study aims to assess the body frame size by elbow breadth and frame index and its relation to body composition parameters among tribal preschool children (1-5 years of age). In the present study, 848 preschool children (430 boys and 418 girls) were included. The mean elbow breadth showed an increasing trend with increasing age, but inverse results were observed in the case of frame index. Age-wise, statistically significant sex differences were found in mean elbow breadth and frame index (except for 2 years of age). Boys show higher mean elbow breadth and frame index in all age groups, and significant sex differences were found. Elbow breadth and frame index had the strongest significant positive correlations with fat free mass (FFM) (r = 0.590, P < 0.01) and FFM index (r = 0.539, P < 0.01), respectively.


Subject(s)
Body Composition , Elbow , Humans , Child, Preschool , India , Male , Female , Infant , Anthropometry , Sex Factors , Age Factors , Body Size
6.
Heliyon ; 8(10): e10961, 2022 Oct.
Article in English | MEDLINE | ID: mdl-36262305

ABSTRACT

The solution grown doped ZnO based transparent electrode has shown great potential in future generation flexible and smart devices due to its abundance in earth, low cost, simple and low temperature synthesis process. But solution grown doped ZnO possesses one major drawback, its mobility decreases rapidly with an increase in doping concentration. To eliminate this issue, the understanding of factors that limiting mobility is a prerequisite. But till date, there are very limited resources with detailed understanding of mobility limiting factors in solution grown TCO. Here in this report, with the morphological, optical and electrical investigations, the mobility limiting factor comes out to be surface related property and assigned to be the defects related to surface adsorbed oxygen and oxygen species at the surface. Furthermore, we have modified the surface to remove the surface adsorbed oxygen species by a low temperature (70 °C) simple solution process. Surface modified sample shows more than two orders of improvement in resistivity without any significant change in the transparency in visible range.

SELECTION OF CITATIONS
SEARCH DETAIL
...